News highlight

Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027

todayFebruary 24, 2026 2

Background
share close

Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027.

Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027.  Read More 

Written by: admin

Rate it

Post comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *